Enquire Now
sponsors

Our Experience

Scientia is one of the most well equipped and capable Phase I facilities in Australia.

Our team have a strong track record of success working with International pharmaceutical & biotechnology companies and we ensure consistency of delivery for our clients. Our teams have extensive experience in:

  • First Time In Human single and multiple dose studies (SAD/MAD) in Healthy Volunteers
  • Drug-Drug interaction, Food Effect, Bioequivalence and other PK studies
  • Biosimilar & Vaccine studies
  • Pharmacodynamic and other efficacy studies
  • Ethno bridging studies supporting submissions to global regulators
  • Specialized Phase 1 Oncology including FIH, Dose Escalation and Dose Expansion
  • Targeted first in patient population studies requiring high levels of medical oversight and confinement
  • First In Human Medical device studies
In collaboration with our established network of specialists from hospitals and clinics throughout NSW, Scientia is one of the few dedicated Phase I Units with the track record and successful history of recruiting a variety of patient populations from a range of different therapeutic disciplines.
 

300+

Studies completed since opening

62%

women in
leadership

24/7

Participant monitorning

15

Languages spoken by our staff

Our Core Values
Our values form the basis of everything we do: how we work with our clients, how we engage with suppliers and third party partners, how we interact with our study participants, and how we communicate amongst our team.
  • Quality – ensuring project deliverables are achived whilst focusing on participant safety and positive participant outcomes
  • Trust through responsibility – acknowledging the role we play in developing new medicine. We’re the guiding hand helping to navigate even the most complex early phase project
  • Clear and concise communication – A clear “one-team” approach, ensuring alignment and progress towards a common goal
  • Predictability and transparency – no surprises, for the client or participant
  • Continuous improvement – adapting and evolving, recognizing that no two projects are ever the same
Enquire Now

Express Interest Japanese studies

Register interest in a clinical trial

"*" indicates required fields

We will give you a call to discuss this study with you and ask some screening questions to see if you might be eligible.
Gender
Do you smoke?*
Your preferred language*
We have staff who speak English and Japanese.
We respect your privacy. By submitting your details you are agreeing to our privacy policy. You can unsubscribe at any time to this page.

임상 연구에 관심이 있는 한국 과목

Register interest in a clinical trial

"*" indicates required fields

임상 시험과 참여 조건에 확인을 위해 전화드리겠습니다.
성
흡연을 하시나요?*
선호하는 언어*
영어와 한국어 구사가 가능한 직원이 있습니다.

 

We respect your privacy. By submitting your details you are agreeing to our privacy policy. You can unsubscribe at any time.